Growth opportunities are abounding in Chinese biotech. A confluence of regulatory reforms, industry talent, and the re-opening of the country’s capital markets have helped propel China’s biotech …
( read original story …)
The HongKong News
Growth opportunities are abounding in Chinese biotech. A confluence of regulatory reforms, industry talent, and the re-opening of the country’s capital markets have helped propel China’s biotech …
( read original story …)